性对肝脏疾病发展的影响
Jie-Wen Zhang1,2,3, Nan Zhang1,2,3, Yi Lyu1,2,3
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
Seminars in liver disease
|January 14, 2025
概括
性差异显著影响肝脏疾病,由荷尔蒙和染色体驱动. 了解这些性别特异性机制对于开发个性化的肝病治疗至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
背景情况:
- 肝脏表现出性二态,在大多数肝脏疾病的流行,进展,预后和治疗方面观察到基于性别的显著差异.
- 驱动这些性差异的肝病病原体的潜在机制仍然不完全理解.
研究的目的:
- 审查和总结目前对导致肝病差异的性别特异机制的理解.
- 突出性激素和性染色体在调节肝病结果中的作用.
主要方法:
- 本综述综合了有关肝病性别差异的现有文献.
- 专注于生物性特异性因素,包括荷尔蒙和遗传影响.
主要成果:
- 性激素 (雌激素和雄激素) 显著影响肝病的发展和进展.
- 性染色体上的遗传因素有助于基因表达,免疫反应和肝脏疾病中的代谢的性别差异.
- 从历史上看,研究一直是性别不平衡的,不充分代表女性受试者.
结论:
- 性别是影响肝脏疾病流行率和结果的关键因素.
- 阐明性别特异性致病机制对于推进男性和女性患者个性化治疗策略至关重要.
- 在研究中解决性别不平衡对于全面理解和有效治疗至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
426
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
426
Sex-linked Disorders
100.2K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
100.2K
Factors Affecting Drug Biotransformation: Biological
105
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
105
Liver Physiology
415
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
415
Factors Influencing Drug Absorption: Disease States and Pharmacology
422
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
422
Hepatic Drug Clearance: Effect of Protein Binding
146
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
146


